Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)
NCT02443948 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2017-02-14
Summary
This observational study is proposed to evaluate if the trend in the levels of cf-DNA evaluated on a sample of peripheral blood may be related to different clinical behaviors of the disease monitored by radiological investigations conducted.
Conditions
- Gastrointestinal Stromal Tumor (GIST)
Interventions
- OTHER
-
Vena puncture for blood collection
Cf-DNA blood samples will be collected in EDTA tubes (20 ml) during the routine blood test
Sponsors & Collaborators
-
Fondazione del Piemonte per l'Oncologia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2017-12-31
- Completion
- 2018-06-30
Countries
- Italy
Study Locations
More Related Trials
-
The ctDNA-RECIST Trial Part One
NCT06562348 ·Status: RECRUITING ·Phase: PHASE2
-
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332 ·Status: UNKNOWN
-
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
NCT04530890 ·Status: RECRUITING ·Phase: NA
-
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
NCT06589388 ·Status: RECRUITING
-
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
NCT03749083 ·Status: WITHDRAWN
-
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133 ·Status: RECRUITING
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
Detection of Plasma Circulating Tumor DNA in Gastric Cancer
NCT05027347 ·Status: UNKNOWN
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED
-
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients
NCT05254821 ·Status: RECRUITING
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN
-
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
NCT00213798 ·Status: COMPLETED ·Phase: NA
-
Early Detection and Post-operative Monitoring of Gastric Cancer
NCT06232395 ·Status: RECRUITING
-
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372 ·Status: UNKNOWN
-
Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy
NCT02133222 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN
-
Prediction of True Oligo-metastatic Disease.
NCT05806151 ·Status: RECRUITING
-
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
NCT02441140 ·Status: TERMINATED ·Phase: NA
-
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056 ·Status: WITHDRAWN
-
Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
NCT03302325 ·Status: COMPLETED
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Cell-free Circulating DNA in Primary Cutaneous Lymphomas
NCT02883517 ·Status: COMPLETED
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer
NCT04947995 ·Status: UNKNOWN